patent

News

Novartis knocked back again in bid to block Gilenya generics...

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US.

News

Natural killer cells are a type of lymphocytes which destroy cancer cells and other altered cells releasing cytotoxic granules.

Merck to pay BMS $625m in cancer patent case

Case settles patent case related to rival immunotherapies.

News

Alexion's shares slide after Soliris patent challenge from A...

Amgen’s famously voracious legal team is living up to its reputation once again, this time with a surprise challenge on the patents surrounding Alexion’s rare diseases blockbuster, Soliris.

News

Novartis probed by Swiss authorities over 'unlawful' patent ...

The competition authorities in Switzerland said this morning they have carried out a raid on a pharma company – now confirmed to be Novartis – as part of an investigation into a "possible u

News

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

The rivalry between Moderna and Pfizer/BioNTech in commercialising their COVID-19 vaccines has now spilled over into the courts, in the form of a patent infringement lawsuit.

News

ViiV claims $1.25bn settlement from Gilead in HIV patent dis...

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV pr

Novartis knocked back again in bid to block Gilenya generics...

Merck to pay BMS $625m in cancer patent case

Alexion's shares slide after Soliris patent challenge from A...

Novartis probed by Swiss authorities over 'unlawful' patent ...

Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech

ViiV claims $1.25bn settlement from Gilead in HIV patent dis...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

patent

Editor's Picks